Clinical Trial Detail

NCT ID NCT04231526
Title Pembrolizumab in Early Stage Colon Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

colon adenocarcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.